KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Capital Employed: 2009-2024

Historic Return on Capital Employed for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to -0.01%.

  • Teva Pharmaceutical Industries' Return on Capital Employed rose 5.00% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 5.00%. This contributed to the annual value of -0.01% for FY2024, which is 2.00% down from last year.
  • According to the latest figures from FY2024, Teva Pharmaceutical Industries' Return on Capital Employed is -0.01%, which was down 177.05% from 0.01% recorded in FY2023.
  • Teva Pharmaceutical Industries' Return on Capital Employed's 5-year high stood at 0.05% during FY2021, with a 5-year trough of -0.09% in FY2020.
  • Its 3-year average for Return on Capital Employed is -0.02%, with a median of -0.01% in 2024.
  • In the last 5 years, Teva Pharmaceutical Industries' Return on Capital Employed increased by 13bps in 2021 and then declined by 11bps in 2022.
  • Teva Pharmaceutical Industries' Return on Capital Employed (Yearly) stood at -0.09% in 2020, then increased by 13bps to 0.05% in 2021, then declined by 11bps to -0.06% in 2022, then rose by 8bps to 0.01% in 2023, then declined by 2bps to -0.01% in 2024.